Heart artery microcirculation and metabolism study
Part of Heart & circulation clinical trials.
This trial looks at the tiny blood vessels in the heart and how they work in people who have no major blockages. It may help understand chest pain that isn't caused by large artery narrowing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart artery test (angiogram) that shows no narrowing or only very mild narrowing (less than 50%).
- You do not have any artery narrowing that is 50% or more.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new method during a routine heart catheterization to measure resistance in the heart arteries and the tiny blood vessels. It helps doctors understand if a treatment like stents or medication would be best for your heart.
This study looks at the tiny blood vessels in your heart (the microcirculation) that can cause chest pain even when the main arteries are open. It aims to better understand and treat this type of chest pain, called chronic coronary syndrome.
This trial is testing a new way to diagnose problems in the small blood vessels of the heart that can cause chest pain even when the main arteries look clear. The test uses a special technique to measure how well these small vessels work, which could help find the cause of your symptoms.
This study examines how a special measurement technique works when blood vessels are dilated during a heart imaging procedure. It may help doctors better assess whether narrowing in your heart arteries needs treatment.
This study looks at a specific heart blood-flow measurement taken during a coronary procedure to see how well it predicts future outcomes. If you had a successful pressure measurement called FFR with a tracing, your results may be analyzed to understand risk and prognosis.
This study follows people who have narrowed heart arteries and have a pressure test (FFR) to guide treatment. It may help doctors understand the course of disease when using FFR and choosing a minimally invasive approach.
Hear when a new Coronary Atherosclerosis of Native Coronary Artery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.